Main
>
RHEUMATOLOGY>RHEUMATOID ARTHRITIS
>
Treatment
>
Tumor Necrosis Factor Inhibitors
>
Co.: BE. U (MAb/Phase III/Patents)
>
Patent
>
US Expiration Date: 06.06.2021
US Expiration Date: 06.06.2021's products
This section has no products